During the past decade, Centrum Kliniczno Badawcze conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 8 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Kliniczno Badawcze" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "AEterna Zentaris" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Asarina Pharma" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Kliniczno Badawcze" #1 collaborator was "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "Ergomed" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Kliniczno Badawcze" are "Arthritis, Psoriatic" (5 trials), "Rheumatoid Arthritis" (2 trials), "Axial Spondyloarthritis" (1 trials), "Growth Hormone Deficiency With Pituitary Anomalies" (1 trials) and "Knee Osteoarthritis" (1 trials). Many other conditions were trialed in "Centrum Kliniczno Badawcze" in a lesser frequency.

Most popular intervention types in "Centrum Kliniczno Badawcze" are "Drug" (14 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Guselkumab" (5 trials), "Apremilast 20 mg" (1 trials), "Apremilast 30 mg" (1 trials) and "Botulinum toxin type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Kliniczno Badawcze" are 15 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centrum Kliniczno Badawcze". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Centrum Kliniczno Badawcze, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Kliniczno Badawcze, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".